Costa, Max
- NYU Grossman School of Medicine · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11,017
- Sustained Excellence
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$941.7K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#11,017
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Costa, Max as a PI. Multi-PI records show the full award amount for context.
- 5R01CA229234-04R01Contact PIMEG3 deletion drives lung tumorigenesis due to environmental nickel exposureNYU Grossman School of Medicine · Pathology (NIH department code)$548.7Kaward amount
- 5R01ES030572-05R01Contact PIArsenic and Nickel Carcinogenesis in Human Lung CellsNYU Grossman School of Medicine · Pathology (NIH department code)$393Kaward amount
Award organization
Organizations that administered FY2023 awards listing Costa, Max as a PI.
FY2023 award administered by NYU Grossman School of Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardNYU Grossman School of Medicine
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #2743
- 2006Entered Top 25% NationallyRanked #2743
- 2007$2M Cumulative Funding
- 2008$5M Cumulative Funding
- 2009Entered Top 10% NationallyRanked #1227
- 2010$10M Cumulative Funding
- 2012R01 Grant Holder
- 2017$25M Cumulative Funding